Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: TransMedics Group, Inc.

Capitalization 4.62B 3.97B 3.59B 3.44B 6.28B 425B 6.47B 42.26B 16.92B 204B 17.35B 16.98B 729B P/E ratio 2026 *
54.6x
P/E ratio 2027 * 36.5x
Enterprise value 4.57B 3.92B 3.54B 3.39B 6.2B 419B 6.39B 41.74B 16.72B 201B 17.14B 16.77B 720B EV / Sales 2026 *
6.2x
EV / Sales 2027 * 5.07x
Free-Float
96.82%
Yield 2026 *
-
Yield 2027 * -
1 day-2.05%
1 week-11.00%
Current month-9.32%
1 month-5.44%
3 months+0.38%
6 months+22.20%
Current year+8.27%
1 week 122.38
Extreme 122.38
151
1 month 122.38
Extreme 122.38
151
Current year 120.17
Extreme 120.171
151.85
1 year 62.23
Extreme 62.23
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 31/07/1998
Director of Finance/CFO 55 01/12/2024
Chief Operating Officer 43 01/02/2023
Director TitleAgeSince
Director/Board Member 57 31/07/1998
Chairman 81 31/12/2010
Director/Board Member 78 31/01/2016
Change 5d. change 1-year change 3-years change Capi.($)
-1.98%-11.00%+99.48%+84.17% 4.62B
-1.03%-0.70%-4.23%-7.22% 189B
-0.76%-1.62%+1.40%+117.74% 175B
-0.17%-2.87%-3.44%-17.35% 141B
-1.59%-4.35%-24.95%+51.98% 107B
-0.05%-0.22%-23.03%-20.99% 51.74B
+2.14%+0.56%+25.14%+15.36% 48.94B
-1.33%-3.43%+5.40%+21.16% 36.68B
-2.25%-5.86%-13.83%-1.89% 34.47B
+0.18%-1.86%-4.16%-13.92% 32.96B
Average -0.67%-3.31%+5.78%+22.90% 82.14B
Weighted average by Cap. -0.66%-2.21%-4.40%+27.62%

Financials

2026 *2027 *
Net sales 737M 633M 572M 548M 1B 67.66B 1.03B 6.73B 2.7B 32.44B 2.76B 2.71B 116B 872M 749M 677M 648M 1.18B 80.09B 1.22B 7.97B 3.19B 38.4B 3.27B 3.2B 137B
Net income 99.85M 85.74M 77.51M 74.21M 136M 9.17B 140M 913M 366M 4.4B 375M 367M 15.74B 160M 137M 124M 119M 217M 14.66B 224M 1.46B 584M 7.03B 599M 586M 25.17B
Net Debt -56.97M -48.92M -44.22M -42.34M -77.33M -5.23B -79.77M -521M -209M -2.51B -214M -209M -8.98B -199M -171M -155M -148M -270M -18.28B -279M -1.82B -729M -8.77B -747M -731M -31.38B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
10/03/26 130.94 $ -2.85% 346,331
09/03/26 134.77 $ +3.98% 1,159,588
06/03/26 129.61 $ -7.47% 1,081,713
05/03/26 140.07 $ -5.14% 838,433
04/03/26 147.66 $ -0.23% 701,868
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
134.77USD
Average target price
158.91USD
Spread / Average Target
+17.91%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW